Literature DB >> 9081621

Decrease in [Ca2+]c but not in cAMP Mediates L-AP4 inhibition of glutamate release: PKC-mediated suppression of this inhibitory pathway.

I Herrero1, E Vázquez, M T Miras-Portugal, J Sánchez-Prieto.   

Abstract

We investigated the mechanism of the inhibition of glutamate release by (L)-2-amino-4-phosphonobutyrate ((L)-AP4) in cerebrocortical nerve terminals from young rats (3 weeks of age). The Ca(2+)-dependent release of glutamate was reduced by (L)-AP4 in a concentration-dependent manner. This inhibitory effect was prevented by pertussis toxin, insensitive to staurosporine and associated with a reduction both in the depolarization-evoked increase in the cytoplasmic free Ca(2+) concentration ([Ca(2+)](c)) and in forskolin-stimulated cAMP formation. However, the reduction in [Ca(2+)](c) but not in cAMP seemed to be responsible for the decrease in release, since inhibition by (L)-AP4 can also be observed in the absence of detectable changes in cAMP The inhibitory modulation by (L)-AP4 was suppressed by the activation of protein kinase C with phorbol esters. The nerve terminals from young rats also exhibited a facilitatory pathway of glutamate release which was mediated by protein kinase C. Interestingly, stimulation of this pathway with the glutamate agonist (1S,3R)-1-aminocyclopentane-1,3-dicarboxylate in the presence of arachidonic acid also abolished the inhibitory action of (L)-AP4. The dominance of the facilitatory pathway in its interaction with the (L)-AP4-mediated inhibitory control may provide some clues to understand the presynaptic changes during synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9081621     DOI: 10.1111/j.1460-9568.1996.tb01255.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

Review 1.  Bioenergetics and transmitter release in the isolated nerve terminal.

Authors:  David G Nicholls
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 2.  Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential.

Authors:  Marion S Mercier; David Lodge
Journal:  Neurochem Res       Date:  2014-08-22       Impact factor: 3.996

3.  Modulation of the dinucleotide receptor present in rat midbrain synaptosomes by adenosine and ATP.

Authors:  M Díaz-Hernández; J Pintor; M T Miras-Portugal
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

4.  Metabotropic glutamate receptors modulate GABA release from mouse hippocampal slices.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

5.  cAMP-dependent protein kinase inhibits mGluR2 coupling to G-proteins by direct receptor phosphorylation.

Authors:  H Schaffhauser; Z Cai; F Hubalek; T A Macek; J Pohl; T J Murphy; P J Conn
Journal:  J Neurosci       Date:  2000-08-01       Impact factor: 6.167

6.  Diurnal and circadian variation of protein kinase C immunoreactivity in the rat retina.

Authors:  R Gabriel; J Lesauter; R Silver; A Garcia-España; P Witkovsky
Journal:  J Comp Neurol       Date:  2001-10-15       Impact factor: 3.215

7.  Involvement of metabotropic glutamate receptors in ischemia-induced taurine release in the developing and adult hippocampus.

Authors:  P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  2000-08       Impact factor: 3.996

8.  The metabotropic glutamate receptor mGlu7 activates phospholipase C, translocates munc-13-1 protein, and potentiates glutamate release at cerebrocortical nerve terminals.

Authors:  Ricardo Martín; Thierry Durroux; Francisco Ciruela; Magdalena Torres; Jean-Philippe Pin; José Sánchez-Prieto
Journal:  J Biol Chem       Date:  2010-04-07       Impact factor: 5.157

9.  Metabotropic glutamate receptors modulate ischemia-induced GABA release in mouse hippocampal slices.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

10.  Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins.

Authors:  T A Macek; H Schaffhauser; P J Conn
Journal:  J Neurosci       Date:  1998-08-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.